LV10922B - Method for stabilizing pranoprofen and stable liquid preparation of pranprofen - Google Patents

Method for stabilizing pranoprofen and stable liquid preparation of pranprofen Download PDF

Info

Publication number
LV10922B
LV10922B LVP-95-50A LV950050A LV10922B LV 10922 B LV10922 B LV 10922B LV 950050 A LV950050 A LV 950050A LV 10922 B LV10922 B LV 10922B
Authority
LV
Latvia
Prior art keywords
pranoprofen
stabilizing
antioxidant
aqueous solution
solution
Prior art date
Application number
LVP-95-50A
Other languages
English (en)
Latvian (lv)
Other versions
LV10922A (lv
Inventor
Koji Doi
Hisako Sawa
Yoshie Ozaki
Yoshiyuki Kimura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of LV10922A publication Critical patent/LV10922A/xx
Publication of LV10922B publication Critical patent/LV10922B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
    • Y10T428/1393—Multilayer [continuous layer]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
LVP-95-50A 1994-03-15 1995-03-14 Method for stabilizing pranoprofen and stable liquid preparation of pranprofen LV10922B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4418494 1994-03-15

Publications (2)

Publication Number Publication Date
LV10922A LV10922A (lv) 1995-12-20
LV10922B true LV10922B (en) 1996-08-20

Family

ID=12684495

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-50A LV10922B (en) 1994-03-15 1995-03-14 Method for stabilizing pranoprofen and stable liquid preparation of pranprofen

Country Status (19)

Country Link
US (2) US5856345A (de)
EP (2) EP1163906A3 (de)
KR (1) KR100338851B1 (de)
CN (1) CN1091597C (de)
AT (1) ATE297206T1 (de)
AU (1) AU707119B2 (de)
BR (1) BR9501081A (de)
CA (1) CA2144591A1 (de)
DE (1) DE69534258T2 (de)
EE (1) EE9500015A (de)
ES (1) ES2240966T3 (de)
FI (1) FI951190A (de)
HU (1) HUT71245A (de)
LT (1) LT3969B (de)
LV (1) LV10922B (de)
NO (1) NO950970L (de)
PL (1) PL179534B1 (de)
RU (1) RU2148402C1 (de)
TW (1) TW358812B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235781B1 (en) 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
CA2359605A1 (en) * 1998-12-02 2000-06-08 Gt Merchandising & Licensing Corp. Gradual hair relaxation composition
BR0313064A (pt) * 2002-07-31 2005-06-28 Pharmacia Corp Forma de dosagem farmacêutica compreendendo um composto de sulfito
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
EP1525884B1 (de) 2002-07-31 2011-10-12 Senju Pharmaceutical Co., Ltd. Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
JP4500261B2 (ja) 2003-01-21 2010-07-14 千寿製薬株式会社 ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US7125497B1 (en) * 2003-05-22 2006-10-24 Sandia Corporation Reactive formulations for a neutralization of toxic industrial chemicals
US20060188557A1 (en) * 2003-05-23 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CN104010661B (zh) * 2011-12-27 2017-06-06 千寿制药株式会社 含有二丁基羟基甲苯的制剂及二丁基羟基甲苯的稳定化方法
JP5345743B1 (ja) * 2012-02-27 2013-11-20 ロート製薬株式会社 眼科用組成物キット
JP5687395B2 (ja) * 2013-02-19 2015-03-18 ロート製薬株式会社 網膜疾患の予防、改善、又は治療用粘膜適用剤
JP5340498B1 (ja) * 2013-03-11 2013-11-13 千寿製薬株式会社 ソフトコンタクトレンズ用眼科用組成物
WO2014192737A1 (ja) * 2013-05-30 2014-12-04 千寿製薬株式会社 クロルフェニラミン又はその塩の安定化方法
TWI644663B (zh) * 2014-03-10 2018-12-21 日商千壽製藥股份有限公司 二丁基羥基甲苯的穩定化方法，及含二丁基羥基甲苯之製品(一)
TW201540292A (zh) * 2014-03-10 2015-11-01 Senju Pharma Co 二丁基羥基甲苯的穩定化方法（二）
AR102172A1 (es) 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida
KR102478553B1 (ko) * 2018-02-28 2022-12-16 한림제약(주) 벤조피란 유도체 또는 이의 약학적으로 허용가능한 염을 포함하는 용액 형태의 점안제
CN115677733A (zh) * 2022-12-20 2023-02-03 济南宣正药业有限公司 一种用于普拉洛芬质量研究的化合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931295A (en) 1974-07-23 1976-01-06 Universal Oil Products Company Hydroxylation of aromatic compounds
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4565851A (en) * 1983-04-25 1986-01-21 Eastman Kodak Company Containers having improved gas barrier properties
US4525348A (en) * 1983-12-19 1985-06-25 Yoshitomi Pharmaceutical Industries, Ltd. Pranoprofen gelled ointment
JPS60184013A (ja) 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JPS61130222A (ja) * 1984-11-30 1986-06-18 Kureha Chem Ind Co Ltd 抗腫瘍剤
US4940728A (en) * 1985-05-17 1990-07-10 Postley John E Treatment for sino-nasal congestion
US5110492A (en) * 1985-05-24 1992-05-05 Irene Casey Cleaner and disinfectant with dye
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
EP0471084B1 (de) * 1990-03-02 1996-01-10 Shiseido Company Limited Wässerige emulsion mit nicht steroidhaltigen entzündungshemmenden schmerzmitteln
TW206918B (de) * 1991-05-11 1993-06-01 Kuko Seiyaku Kk
JPH05124092A (ja) * 1991-11-06 1993-05-21 Chisso Corp ポリオレフイン系樹脂製中空容器
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion

Also Published As

Publication number Publication date
RU2148402C1 (ru) 2000-05-10
BR9501081A (pt) 1996-06-04
ATE297206T1 (de) 2005-06-15
NO950970D0 (no) 1995-03-14
EP1163906A2 (de) 2001-12-19
LT95028A (en) 1995-10-25
HUT71245A (en) 1995-11-28
EP0672414A2 (de) 1995-09-20
FI951190A0 (fi) 1995-03-14
DE69534258T2 (de) 2006-05-04
EP0672414A3 (de) 1995-12-13
AU1485295A (en) 1995-09-21
KR100338851B1 (ko) 2002-10-12
PL307671A1 (en) 1995-09-18
EP0672414B1 (de) 2005-06-08
EE9500015A (et) 1995-12-15
TW358812B (en) 1999-05-21
PL179534B1 (pl) 2000-09-29
CA2144591A1 (en) 1995-09-16
DE69534258D1 (de) 2005-07-14
AU707119B2 (en) 1999-07-01
KR950032201A (ko) 1995-12-20
ES2240966T3 (es) 2005-10-16
CN1111510A (zh) 1995-11-15
FI951190A (fi) 1995-09-16
NO950970L (no) 1995-09-18
LT3969B (en) 1996-05-27
CN1091597C (zh) 2002-10-02
LV10922A (lv) 1995-12-20
US5856345A (en) 1999-01-05
US5889030A (en) 1999-03-30
HU9500772D0 (en) 1995-04-28
EP1163906A3 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
US5889030A (en) Method for stabilizing pranoprofen and stable liquid preparation of pranaprofen
JP3021312B2 (ja) プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
EP1098649B1 (de) Stabilisierung pharmazeutischer zusammensetzungen durch besonderen einsatz eines antioxidans
US10471026B2 (en) Norepinephrine compositions and methods therefor
EP2281554A1 (de) Augentropfen enthaltend Ketotifen
KR20080041621A (ko) 잔탄 검 및 테르페노이드를 포함하는 점안제
KR20020081293A (ko) 페메트렉시드를 모노티오글리세롤 ｌ-시스테인 또는티오글리콜산과 함께 포함하는 제약 조성물
KR20010080136A (ko) 비타민 ａ 및 비타민 ｅ를 포함하는 안과용 조성물의 용도
JP2005015368A (ja) プラノプロフェン含有水性液剤の安定化方法
EP1916002B1 (de) Verfahren zur prävention der zersetzung einer thermisch instabilen substanz
JP3199475B2 (ja) ビタミンａ類可溶化水溶液の安定化法
CA2466851A1 (en) Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
JP2008120764A (ja) プロスタグランジン水性点眼剤
AU615454B2 (en) Doxorubicin hydrochloride nonaqueous solution
JPWO2018225729A1 (ja) ソフトコンタクトレンズ用眼科用組成物及びビタミンａ分離抑制方法
JP2004123634A (ja) 眼科用組成物
CA2217360A1 (en) Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
JP7379913B2 (ja) ソフトコンタクトレンズ用眼科組成物及び眼科用製品
JPH08333257A (ja) 塩酸プロカテロール水溶液製剤収容製品及び塩酸プロカテロール水溶液製剤
CA3147218A1 (en) Infusion dosage form of norepinephrine
TW201929904A (zh) 眼科用製品及掩蔽方法